Tag: Emyria

The Australian psychedelic-assisted therapy provider has reported record quarterly revenue of $1.42 million, expanded its national clinic network and received ...

Emyria has begun treating its first patients at a new Sydney clinic, extending its Empax mental health services into New ...

Australian psychedelic medicine company Emyria has brought former US Secretary of Veterans Affairs Dr David Shulkin into its strategy as ...

Australian psychedelic medicine company Emyria Limited (ASX: EMD) has been selected by the US Food and Drug Administration (FDA) to ...

Emyria (ASX: EMD) is preparing to open its first Sydney clinic in September, with the company saying key operational milestones ...

Australia's listed cannabis sector has become increasingly difficult to define simply as "cannabis". The latest results show companies moving in ...

Emyria (ASX: EMD) has cleared a key operational bottleneck across its Perth and Queensland psychedelic-assisted therapy operations, with therapist availability ...

Emyria is building a second business behind its growing mental health operation: a drug discovery and development programme focused on ...

When Australia became the first country to permit authorised psychiatrists to prescribe MDMA and psilocybin for specific mental health conditions ...

Emyria (ASX: EMD) has released its June 2026 quarterly update, highlighting strong revenue growth, national clinic expansion and encouraging early ...